Cutaneous lichen amyloidosis is a chronic dermatosis marked by persistent pruritus, pigmentary change, and papule formation. A structured first-line approach exists with defined clinical goals and a maintenance phase.
The evidence-based first-line approach centres on topical therapy applied on a daily schedule, with a transition to a less frequent maintenance regimen once the primary symptom burden is adequately controlled. The complete agent, schedule, and maintenance criteria are detailed in the full protocol.
The primary targets are significant reduction of pruritus, pigmentation, and papules.
DOI: 10.4103/pigmentinternational.pigmentinternational_